Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Take action
Contact the company
📍Recalling firmB. Braun Medical Inc2525 McGaw Ave · Irvine, CA 92614-5841
✎ GovInfoNow plain-language explainer
B. Braun Medical Inc is recalling a specific lot of Cefepime for Injection USP and Dextrose Injection USP because it contains visible organic particulate matter. This Class I recall affects 18,936 containers distributed nationwide. The product is intended for intravenous use only. Read more at govinfonow.com/recall/46552-b-braun-medical-inc-recalls-cefepime-for-injection-usp-and.
“B. Braun Recalls Cefepime/Dextrose Injection for Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46552-b-braun-medical-inc-recalls-cefepime-for-injection-usp-and. Based on FDA recall #D-1054-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1054-2014%22&limit=1).
B. Braun Medical Inc. recalled Cefepime for Injection USP and Dextrose Injection USP due to the presence of visible organic particulate matter, according to a Food and Drug Administration announcement on Oct. 15, 2013.
How to tell if you have it
Brand: B. Braun Medical
Product: Cefepime for Injection USP and Dextrose Injection USP in Duplex Drug Delivery System, 1 g in 50 mL duplex container
NDC: 0264-3193-11
Lot code: H3A744
Expiration date: 01/15
Quantity: 18,936 containers
The hazard
The FDA said the 1g Cefepime for Injection USP and Dextrose Injection USP lot contains visible organic particulate matter found in a reserve sample unit.
Context
GovInfoNow's records show B Braun Medical Inc. has 66 other recalls on record since Nov. 21, 2013. Other recent recalls of similar products include B. Braun Medical 100mL Sodium Chloride Injection Recall (Aug. 19, 2026), B. Braun Medical Lactated Ringer's Injection Recall (Aug. 12, 2026), and B Braun Discofix Four Way Stopcock Recall (Aug. 4, 2026). Other recent recalls of similar products include GE Healthcare Omnipaque Injection Recall (March 24, 2026), GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026), and American Regent Aminocaproic Acid Injection Recall (July 24, 2026).
How to tell if you have this one
Check for Cefepime for Injection USP and Dextrose Injection USP in a Duplex Drug Delivery System, 1 g in 50 mL duplex container. Look for NDC 0264-3193-11, Lot H3A744, and expiration date 01/15. The product was distributed nationwide.
Brand
B. Braun Medical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using the Product
Do not administer or use any units of the recalled Cefepime for Injection USP and Dextrose Injection USP containing visible particulate matter.
Identify Affected Lots
Verify if your inventory includes NDC 0264-3193-11, Lot H3A744, with an expiration date of 01/15.
Contact Manufacturer
Reach out to B. Braun Medical Inc for further instructions on returning or disposing of the recalled containers.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1054-2014 (October 15, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1054-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.